
Biotech's Future: Gene Editing, Ancient DNA, and Embryo Screening to Lead in 2026
Gene editing technologies, including base editing, are poised to revolutionize biotech by 2026, offering potential cures for genetic disorders like the one affecting KJ Muldoon, who received a personalized treatment. Additionally, advancements in ancient DNA resurrection and polygenic embryo screening are sparking both excitement and ethical debates within the industry, potentially reshaping how we approach disease prevention and personalized medicine. These breakthroughs highlight the transformative power of biotech while raising important questions about responsible innovation and equitable access.



















Discussion
대화에 참여하세요
첫 댓글을 남겨보세요